U.S. market Closed. Opens in 17 hours 4 minutes

CRVO | CervoMed Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue7.14MN/AN/AN/AN/A
Cost of Revenue8.44M1.34M93.42K103.17K97.92K
Gross Profit-1.29M-1.34M-93.42K-103.17K-97.92K
Operating Expenses14.96M3.48M15.94M15.87M11.45M
Selling, General & Admin6.52M2.14M7.45M6.44M4.83M
Research & Development8.44M1.34M8.50M9.43M6.62M
Other Operating Expenses5.42M-2.39MN/AN/AN/A
Operating Income-7.81M-3.48M-16.04M-15.97M-11.55M
Other Expenses / Income5.64M-2.33M-8.50M114.25K85.31K
Before Tax Income-2.17M-5.80M-24.54M-15.86M-11.47M
Income Tax Expenses800.00K-3.48M-443.89K-1.68M332.88K
Net Income-2.17M-5.80M-24.10M-14.19M-11.80M
Interest ExpensesN/A587.00N/AN/AN/A
Basic Shares Outstanding2.66M518.14K1.30M717.76K89.42K
Diluted Shares Outstanding2.66M518.14K1.30M717.76K89.42K
EBITDA-7.81M-3.48M-15.94M-15.87M-11.45M
EBITDA Margin-109.35%0.00%0.00%0.00%0.00%
EBIT-1.37M-9.28M-24.54M-15.86M-11.47M
EBIT Margin-19.20%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙